Rydex S&P 500 Pure Value H holds a quantitatively derived Negative Morningstar Medalist Rating. The rating indicates the model sees limited potential for the strategy to outperform peers on a risk-adjusted basis over a full market cycle.
Rydex S&P 500 Pure Value Fund Class H RYZAX
- NAV / 1-Day Return 138.08 / +1.41 %
- Total Assets 9.9M
-
Adj. Expense Ratio
1.550%
- Expense Ratio 1.550%
- Distribution Fee Level High
- Share Class Type No Load
- Category Large Value
- Investment Style Mid Value
- Min. Initial Investment 2,500
- Status Open
- TTM Yield 0.18%
- Turnover 2,642%
USD | NAV as of Jun 13, 2026 | 1-Day Return as of Jun 13, 2026, 12:11 AM GMT+0
Morningstar’s Analysis RYZAX
Will RYZAX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
The People Pillar is our evaluation of the RYZAX management team’s experience and ability. We find that high-quality management teams deliver superior performance relative to their benchmarks and/or peers.
Parent Pillar
The Parent Pillar is our rating of RYZAX’s parent organization’s priorities and whether they’re in line with investors’ interests.
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 19.6
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Bunge Global SA | 2.40 | 270,579 | Consumer Defensive |
The Mosaic Co | 2.08 | 234,492 | Basic Materials |
Ford Motor Co | 2.05 | 230,644 | Consumer Cyclical |
Archer-Daniels-Midland Co | 2.00 | 224,748 | Consumer Defensive |
Tyson Foods Inc Class A | 1.94 | 218,202 | Consumer Defensive |
General Motors Co | 1.91 | 214,872 | Consumer Cyclical |
Centene Corp | 1.89 | 212,701 | Healthcare |
Dow Inc | 1.84 | 207,093 | Basic Materials |
Molina Healthcare Inc | 1.82 | 204,553 | Healthcare |
The Cigna Group | 1.70 | 191,055 | Healthcare |
United States